Lexeo Therapeutics (LXEO) Gross Profit: 2022-2023
Historic Gross Profit for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to -$50,000.
- Lexeo Therapeutics' Gross Profit rose 7.41% to -$50,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$205,000, marking a year-over-year change of. This contributed to the annual value of -$137,000 for FY2024, which is 33.17% up from last year.
- As of Q4 2023, Lexeo Therapeutics' Gross Profit stood at -$50,000, which was up 3.85% from -$52,000 recorded in Q3 2023.
- Lexeo Therapeutics' Gross Profit's 5-year high stood at $531,000 during Q3 2022, with a 5-year trough of -$54,000 in Q4 2022.
- Over the past 2 years, Lexeo Therapeutics' median Gross Profit value was -$51,000 (recorded in 2023), while the average stood at $45,333.
- Data for Lexeo Therapeutics' Gross Profit shows a peak YoY increase of 7.41% (in 2023) and a maximum YoY decrease of 109.79% (in 2023) over the last 5 years.
- Over the past 2 years, Lexeo Therapeutics' Gross Profit (Quarterly) stood at -$54,000 in 2022, then rose by 7.41% to -$50,000 in 2023.
- Its Gross Profit was -$50,000 in Q4 2023, compared to -$52,000 in Q3 2023 and -$53,000 in Q2 2023.